Zydus Lifesciences Ltd Quarterly Results

Gross Sales

6,037.9

6,467

6,290.2

5,123.5

5,113.6

Excise Duty

0

0

0

0

0

Net Sales

6,037.9

6,467

6,290.2

5,123.5

5,113.6

Other Operating Income

85.3

106.7

237.7

145.6

123.4

Other Income

109

154.9

80.6

57.5

68.5

Total Income

6,232.2

6,728.6

6,608.5

5,326.6

5,305.5

Total Expenditure

4,141.6

4,485.2

4,622

3,881.8

3,775.6

PBIDT

2,090.6

2,243.4

1,986.5

1,444.8

1,529.9

Interest

101.3

84.7

76.6

32

25.1

PBDT

1,989.3

2,158.7

1,909.9

1,412.8

1,504.8

Depreciation

301.9

238.1

237.9

229

233.6

Minority Interest Before NP

0

0

0

0

0

Tax

378.8

230.7

990.6

39.3

365.6

Deferred Tax

75.2

203.3

-567.4

140.2

7.5

Reported Profit After Tax

1,233.4

1,486.6

1,248.8

1,004.3

898.1

Minority Interest After NP

-20

54.2

72.8

2.7

9

Net Profit after Minority Interest

1,258.6

1,466.8

1,170.9

1,023.5

911.2

Extra-ordinary Items

-25

0

-89.49

-0.3

0.3

Adjusted Profit After Extra-ordinary item

1,283.6

1,466.8

1,260.39

1,023.8

910.9

EPS (Unit Curr.)

12.51

14.58

11.64

10.17

9.06

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

100.6

100.6

100.6

100.6

100.6

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

34.62

34.68

31.58

28.19

29.91

PBDTM(%)

32.94

33.38

30.36

27.57

29.42

PATM(%)

20.42

22.98

19.85

19.6

17.56